Effect of a carcinogenic oral dose of 7, 12-dimethylbenz(a)anthracene on receptor binding of estradiol-17 beta in uterus and mammary tissue throughout lactation in the rat.

D. Keightley,A. Okey
IF: 11.2
1974-03-01
Cancer Research
Abstract:Ingestion of 15 mg of 7,12-dimethylbenz(a)anthracene (DMBA) by lactating Sprague-Dawley rats increased the number of estrogen receptor sites in mammary cytosol fraction and decreased slightly the intrinsic association constant for the estradiol-receptor interaction. These effects were first seen 2 days after treatment, but there were no differences between control and DMBA-treated animals at 20 days after treatment. In the uterus there were no significant differences in the number of binding sites between control and DMBA-treated animals at any point during lactation. Direct measurements of estradiol-17β by a radioreceptor assay indicated reduced levels of the endogenous steroid in both mammary gland and uterus following DMBA treatment, but such a reduction could not account for the apparent increase in binding sites in mammary tissue. More likely, there was an increase in the proportion of epithelial cells to fat cells in the mammary glands of DMBA-treated rats, increasing the total amount of estrogen receptor in the gland.
What problem does this paper attempt to address?